These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18189292)

  • 1. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.
    Kapp DS; Shin JY; Chan JK
    Cancer; 2008 Feb; 112(4):820-30. PubMed ID: 18189292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
    Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
    Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
    Garg G; Kruger M; Christensen C; Deppe G; Toy EP
    Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
    Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.
    Tan PS; Koh E; Pang C; Ong WS; Ngo L; Soh LT; Quek R; Chay WY; Ho TH; Tay SK; Chew SH; Lim-Tan SK; Khoo-Tan H; Lim SL; Busmanis I; Goh LK; Chia YN; Chia WK; Lim T
    Oncologist; 2012; 17(10):1286-93. PubMed ID: 22829569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
    Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
    J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone.
    Mahdi H; Nutter B; Abdul-Karim F; Amarnath S; Rose PG
    J Gynecol Oncol; 2016 Mar; 27(2):e19. PubMed ID: 26463437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
    Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
    Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
    Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
    Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
    J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of race/ethnicity on prognosis in patients who underwent surgery for colon cancer: analysis for white, African, and East Asian Americans.
    Hashiguchi Y; Hase K; Ueno H; Shinto E; Naito Y; Kajiwara Y; Kuroda T; Yamamoto J; Mochizuki H
    Ann Surg Oncol; 2012 May; 19(5):1517-28. PubMed ID: 22012028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial/ethnic differences in upper-tract urothelial cancer.
    Hosain GM; Khan MM; Amiel GE; Lerner SP; Latini DM; Chen GJ
    Ethn Dis; 2012; 22(3):295-301. PubMed ID: 22870572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive lymphadenectomy and survival prediction in uterine serous cancer patients after surgery: A population-based analysis.
    Li H; Xie X; Liu Y; Huang X; Lin H; Li J; Lin Z
    Eur J Surg Oncol; 2020 Jul; 46(7):1339-1346. PubMed ID: 32402510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race influences stage-specific survival in gastric cancer.
    Howard JH; Hiles JM; Leung AM; Stern SL; Bilchik AJ
    Am Surg; 2015 Mar; 81(3):259-67. PubMed ID: 25760201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
    Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
    Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.